Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Virtual Reality (VR) Self-Hypnosis Software

NCT: NCT06398847 · RECRUITING

NCT IDNCT06398847
StatusRECRUITING
Start Date2026-03-26
Completion2026-06-30

Brief Summary

This single-site study of self-hypnosis software using an off-the-shelf virtual reality (VR) device (OculusGo™) to determine the software's safety, usability, and preliminary efficacy in pain relief for HIV-associated chronic pain patients. This is funded under the i Prism Funding through Mount Sinai Innovations.

Frequently Asked Questions

What is Virtual Reality (VR) Self-Hypnosis Software?

Virtual Reality (VR) Self-Hypnosis Software is a clinical trial registered under NCT06398847. Current status: RECRUITING.

What is the status of NCT06398847?

The current status of NCT06398847 (Virtual Reality (VR) Self-Hypnosis Software) is: RECRUITING.

When did Virtual Reality (VR) Self-Hypnosis Software start?

Virtual Reality (VR) Self-Hypnosis Software started on 2026-03-26.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑